Barlow Wealth Partners, Inc. Astrazeneca PLC Transaction History
Barlow Wealth Partners, Inc.
- $765 Billion
- Q3 2024
A detailed history of Barlow Wealth Partners, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Barlow Wealth Partners, Inc. holds 240,887 shares of AZN stock, worth $16 Million. This represents 2.42% of its overall portfolio holdings.
Number of Shares
240,887
Previous 236,088
2.03%
Holding current value
$16 Million
Previous $18.8 Billion
1.6%
% of portfolio
2.42%
Previous 2.61%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.17 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.78 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $205B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...